Anemia and Heart Failure: A Narrative Review
- PMID: 36017290
- PMCID: PMC9393312
- DOI: 10.7759/cureus.27167
Anemia and Heart Failure: A Narrative Review
Abstract
Anemia in heart failure patients is a relatively common finding and has been linked with an increased risk of hospital admissions, morbidities, and significant mortality making its correction a significant factor in improving the quality of life and clinical outcomes in those suffering from it. This review article has discussed the multifactorial pathophysiology, including iron deficiency, longstanding inflammation, abnormal levels of human erythropoietin (Epo), and the abnormal activation of the renin-angiotensin-aldosterone system (RAAS) being the most significant. The diagnostic guidelines as well as research-based management modalities specifically with iron supplements and erythropoietin stimulating agents have also been discussed, although research done in this area has been limited and shown conflicting results.
Keywords: anaemia of chronic disease (acd); anemia; congestive heart faiulre; epo; heart failure; iron deficiency anaemia (ida).
Copyright © 2022, Siddiqui et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Benjamin EJ, Muntner P, Alonso A, et al. Circulation. 2019;139:0. - PubMed
-
- WHO WHO. Geneva, World Health Organization: Department of Nutrition for Health and Development (NHD) World Health Organization; 2011. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity.
-
- Anemia and mortality in heart failure patients a systematic review and meta-analysis. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. J Am Coll Cardiol. 2008;52:818–827. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials